Publication in Contemporary Clinical Trials

To improve drug regimen use, we propose an adaptive point-of-care (APoC) platform trial for robust real-world evidence (RWE) production, addressing uncertainties post-market. Using rheumatoid arthritis as a case study, this trial integrates adaptive clinical trials and routine clinical care into a sustainable platform. Engaging key stakeholders and focusing on meaningful research questions and metrics are crucial for its success, with the potential to enhance clinical decisions and operational efficiency.

Read the article at PubMed